Alimian Mahzad, Imani Farnad, Hassani Valiollah, Rahimzadeh Poupak, Sharifian Mahshid, Safari Saeid
Department of Anesthesiology, Rasoul-Akram Medical Center, Iran University of Medical Sciences, Tehran, IR Iran.
Anesth Pain Med. 2012 Fall;2(2):72-6. doi: 10.5812/aapm.4301. Epub 2012 Sep 13.
Postoperative pain of dacryocystorhinostomy (DCA) surgery is one of the serious issues to be considered. Administrating opioids to relieve postoperative pain and facing their increasing side effects in eye surgeries, make the use of non-opioid drugs inevitable.
The present study examined the efficacy of pregabalin in alleviating the postoperative pain of DCA surgery.
The present study has been carried out as a double-blind, randomized clinical trial on the patient candidates for DCR. The patients were randomly divided in to two groups of pregabalin and placebo. Patients in pregabalin group received 300 mg of pregabalin, an hour before the operation in the morning of the surgery. Pain intensity on visual analog scale (VAS) was recorded until 24 hours after the operation; also the rate of administrated opioids and nausea/vomiting frequency were recorded during the first 24-hour period after the operation and the resultsof the two groups were compared.
Postoperative pain intensity in the pregabalin group at the time of recovery was significantly lower than that of the placebo group (P = 0.001) until 24 hours after the surgery. In the pregabalin group 17.5% of the patients received opioids while in the placebo group the figure was 52.5% (P = 0.001). Nausea frequency was also higher in the placebo group than the pregabalin group (P = 0.003).
A single 300 mg dose of pregabalin, an hour before DCA can effectively reduce pain intensity and also reduce opioid dose and nausea/vomiting.
泪囊鼻腔吻合术(DCA)术后疼痛是需要考虑的严重问题之一。在眼科手术中使用阿片类药物缓解术后疼痛并应对其日益增加的副作用,使得使用非阿片类药物成为必然。
本研究考察普瑞巴林缓解DCA手术术后疼痛的疗效。
本研究作为一项双盲、随机临床试验,针对DCR候选患者开展。患者被随机分为普瑞巴林组和安慰剂组。普瑞巴林组患者在手术当天上午手术前1小时服用300mg普瑞巴林。记录视觉模拟量表(VAS)上的疼痛强度直至术后24小时;同时记录术后首个24小时内阿片类药物的使用频率及恶心/呕吐的发生频率,并比较两组结果。
术后直至24小时,普瑞巴林组恢复时的术后疼痛强度显著低于安慰剂组(P = 0.001)。普瑞巴林组17.5%的患者使用了阿片类药物,而安慰剂组这一数字为52.5%(P = 0.001)。安慰剂组的恶心发生率也高于普瑞巴林组(P = 0.003)。
DCA术前1小时单次服用300mg普瑞巴林可有效降低疼痛强度,并减少阿片类药物用量及恶心/呕吐的发生。